Media

Pretzel Therapeutics Launches With $72.5 Million Series A Financing to Pioneer Mitochondrial Therapies

Precirix enters into collaboration with Eckert & Ziegler for the development of its 68Ga-based compounds

Oncopeptides receives 5 MSEK grant for NK-cell engager project in multiple myeloma

CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema

Vicore update on the AIR phase 2 trial in idiopathic pulmonary fibrosis

Emactuzumab designated as an Orphan Medicinal Product in Europe

Fusion Pharmaceuticals Announces First Patient Dosed In Phase 1/2 Study Of FPI-1966 In Patients With Advanced Solid Tumors Expressing FGFR3

Interim report April – June 2022

Vicore announces multiple scientific abstracts and presentations at upcoming conferences during the autumn

European Commission approves Oncopeptides’ Pepaxti for the treatment of patients with relapsed refractory multiple myeloma